A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT‐birch pollen extract for the treatment of allergic rhinitis: results of a phase II study

BACKGROUND: Sublingual immunotherapy (SLIT) is a potential efficacious and safe treatment option for patients with respiratory, IgE‐mediated allergic diseases. A combined tolerability, dose‐finding study with a sublingual liquid birch pollen preparation (SB) was conducted. METHODS: Two hundred and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaar, O., van Twuijver, E., Boot, J. D., Opstelten, D. J. E., Klimek, L., van Ree, R., Diamant, Z., Kuna, P., Panzner, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057302/
https://www.ncbi.nlm.nih.gov/pubmed/26417901
http://dx.doi.org/10.1111/all.12760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057302/
https://www.ncbi.nlm.nih.gov/pubmed/26417901
http://dx.doi.org/10.1111/all.12760

Ejemplares similares